GAD65-Ab encephalitis and subtle focal status epilepticus.


Journal

Epileptic disorders : international epilepsy journal with videotape
ISSN: 1950-6945
Titre abrégé: Epileptic Disord
Pays: United States
ID NLM: 100891853

Informations de publication

Date de publication:
01 Oct 2019
Historique:
pubmed: 28 10 2019
medline: 6 5 2020
entrez: 26 10 2019
Statut: ppublish

Résumé

To delineate common epilepsy features associated with the presence of glutamic acid decarboxylase autoantibodies (GAD65-Ab). Three consecutive cases of GAD65-Ab encephalitis patients, followed in our neurological department, were investigated with regards to clinical semiology and EEG. These patients presented new-onset subtle ictal clinical features. Patients 1 and 2 described prolonged and transitory feelings of "déjà vu - déjà vécu" and a "dreamy state". Patient 3 was admitted for subsequent transient aphasia events followed by paroxysmal behavioural disturbances. Epileptic origin of the symptoms was confirmed using either a standard EEG (observation of temporal status epilepticus in one case) or a prolonged EEG (focal epileptiform activity during an asymptomatic period for two patients). All patients suffered from clinical focal status epilepticus. Patients 1 and 2 presented with temporo-mesial seizures in agreement with the definition for limbic encephalitis, whereas Patient 3 presented with neocortical (lateral temporal and frontal lobe) seizures arguing for a non-limbic encephalitis. A high level of GAD65-Ab was found in cerebral spinal fluid, confirming a diagnosis of epilepsy associated with GAD65-Ab encephalitis. Encephalitis seems to be a frequent neurological syndrome associated with GAD65-Ab disorders. Epilepsy may be more frequent and severe than currently suggested, as ictal semiology may be subtle for these outpatients in whom standard EEG is commonly falsely reassuring. Subtle focal status epilepticus is a particular semiology of the GAD65-Ab encephalitis spectrum.

Identifiants

pubmed: 31649008
pii: epd.2019.1094
doi: 10.1684/epd.2019.1094
doi:

Substances chimiques

Autoantibodies 0
Glutamate Decarboxylase EC 4.1.1.15

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

437-442

Auteurs

Mathilde Goudot (M)

Department of Neurology, University Hospital of Nancy.

Solène Frismand (S)

Department of Neurology, University Hospital of Nancy.

Lucie Hopes (L)

Department of Neurology, University Hospital of Nancy.

Antoine Verger (A)

Department of Nuclear medicine, University Hospital of Nancy.

Bastien Joubert (B)

French Reference Center of Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Department of Neurology, INSERM U1217/CNRS, UMR5310, Lyon.

Jérôme Honnorat (J)

French Reference Center of Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Department of Neurology, INSERM U1217/CNRS, UMR5310, Lyon.

Louise Tyvaert (L)

Department of Neurology, University Hospital of Nancy, University of Lorraine, Faculty of Medicine, CRAN CNRS UMR 7039, Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH